BrainStorm Cell Therapeutics
BCLI
#10401
Rank
S$8.66 M
Marketcap
S$0.78
Share price
0.83%
Change (1 day)
-62.96%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Net assets

Net assets on the balance sheet as of June 2025 : -S$7.86 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company has -S$7.86 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BrainStorm Cell Therapeutics - Net assets on balance sheet (from 2002 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-S$10.56 Million64.49%
2023-12-31$-S$6.42 Million58.74%
2022-12-31$-S$4.05 Million-115.46%
2021-12-31$S$26.14 M-44.27%
2020-12-31$S$46.91 M-384.71%
2019-12-31$-S$16.48 Million-340.47%
2018-12-31$S$6.85 M-12.87%
2017-12-31$S$7.86 M-45.12%
2016-12-31$S$14.33 M-28.29%
2015-12-31$S$19.98 M126.58%
2014-12-31$S$8.81 M154.16%
2013-12-31$S$3.47 M-28.74%
2012-12-31$S$4.86 M152.7%
2011-12-31$S$1.92 M-425.93%
2010-12-31$-S$0.6 Million-75.84%
2009-12-31$-S$2.45 Million-17.58%
2008-12-31$-S$2.97 Million-15.03%
2007-12-31$-S$3.5 Million25.47%
2006-12-31$-S$2.79 Million
2006-03-31$-S$12.88 Million-1201.95%
2005-03-31$S$1.16 M-2324.34%
2004-03-31$-S$0.06 Million-246.1%
2003-03-31$S$0.03 M-62.67%
2002-03-31$S$0.09 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
S$27.83 B-354,334.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$0.68 Billion 8,503.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
S$3.30 B-42,206.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$23.62 B-300,702.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-S$0.37 Billion 4,537.08%๐Ÿ‡บ๐Ÿ‡ธ USA